ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT) Stock Price, Forecast & Analysis

USA • Nasdaq • NASDAQ:ZYBT • KYG989MS1016

0.8757 USD
-0.06 (-6.84%)
At close: Feb 3, 2026
0.8789 USD
+0 (+0.37%)
After Hours: 2/3/2026, 8:00:03 PM

ZYBT Key Statistics, Chart & Performance

Key Statistics
Market Cap41.50M
Revenue(TTM)303.21M
Net Income(TTM)39.27M
Shares47.39M
Float4.17M
52 Week High14.3
52 Week Low0.86
Yearly Dividend0.05
Dividend Yield0%
EPS(TTM)0.12
PE7.3
Fwd PEN/A
Earnings (Next)N/A
IPO2025-01-07
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
ZYBT short term performance overview.The bars show the price performance of ZYBT in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

ZYBT long term performance overview.The bars show the price performance of ZYBT in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of ZYBT is 0.8757 USD. In the past month the price decreased by -23.85%. In the past year, price decreased by -79.2%.

ZHENGYE BIOTECHNOLOGY HOLDIN / ZYBT Daily stock chart

ZYBT Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

ZYBT Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to ZYBT. Both the profitability and the financial health of ZYBT get a neutral evaluation. Nothing too spectacular is happening here.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ZYBT Financial Highlights

Over the last trailing twelve months ZYBT reported a non-GAAP Earnings per Share(EPS) of 0.12. The EPS increased by 21.94% compared to the year before.


Industry RankSector Rank
PM (TTM) 12.95%
ROA 7.96%
ROE 13.83%
Debt/Equity 0.02
Chartmill High Growth Momentum
EPS Q2Q%-64.04%
Sales Q2Q%-11.95%
EPS 1Y (TTM)21.94%
Revenue 1Y (TTM)43.18%

ZYBT Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

ZYBT Ownership

Ownership
Inst Owners0.33%
Ins Owners6.53%
Short Float %0.51%
Short Ratio1.05

ZYBT Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
LLY ELI LILLY & CO30.29948.651B
JNJ JOHNSON & JOHNSON20.17561.608B
MRK MERCK & CO. INC.21.41287.517B
PFE PFIZER INC8.58146.521B
BMY BRISTOL-MYERS SQUIBB CO9.22113.982B
ZTS ZOETIS INC17.8753.945B
RPRX ROYALTY PHARMA PLC- CL A8.2824.804B
VTRS VIATRIS INC5.4215.756B
ELAN ELANCO ANIMAL HEALTH INC23.0912.098B
AXSM AXSOME THERAPEUTICS INC229.359.444B

Related stock screener links

View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges

About ZYBT

Company Profile

ZYBT logo image Zhengye Biotechnology Holding Ltd. engages in the manufacture and sale of veterinary vaccines. The company is headquartered in Jilin, Jilin and currently employs 277 full-time employees. The company went IPO on 2025-01-07. The firm markets a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The firm owns about 44 veterinary vaccines in its product portfolio, which cover veterinary vaccines for livestock, including monovalent vaccine, polyvalent vaccine, combined vaccine and combined and polyvalent vaccine. The firm also engages in vaccines for treating livestock. The firm mainly conducts its business in the domestic market. The firm mainly conducts its business in the domestic and overseas market.

Company Info

ZHENGYE BIOTECHNOLOGY HOLDIN

No.1 Lianmeng Street, Jilin Economic &, Technical Development Zone

Jilin JILIN CN

Employees: 277

ZYBT Company Website

ZHENGYE BIOTECHNOLOGY HOLDIN / ZYBT FAQ

What does ZHENGYE BIOTECHNOLOGY HOLDIN do?

Zhengye Biotechnology Holding Ltd. engages in the manufacture and sale of veterinary vaccines. The company is headquartered in Jilin, Jilin and currently employs 277 full-time employees. The company went IPO on 2025-01-07. The firm markets a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The firm owns about 44 veterinary vaccines in its product portfolio, which cover veterinary vaccines for livestock, including monovalent vaccine, polyvalent vaccine, combined vaccine and combined and polyvalent vaccine. The firm also engages in vaccines for treating livestock. The firm mainly conducts its business in the domestic market. The firm mainly conducts its business in the domestic and overseas market.


What is the stock price of ZHENGYE BIOTECHNOLOGY HOLDIN today?

The current stock price of ZYBT is 0.8757 USD. The price decreased by -6.84% in the last trading session.


What is the dividend status of ZHENGYE BIOTECHNOLOGY HOLDIN?

ZYBT does not pay a dividend.


How is the ChartMill rating for ZHENGYE BIOTECHNOLOGY HOLDIN?

ZYBT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What is the market capitalization of ZYBT stock?

ZHENGYE BIOTECHNOLOGY HOLDIN (ZYBT) has a market capitalization of 41.50M USD. This makes ZYBT a Nano Cap stock.